USA Pharmacovigilance Congress 2023: Join Industry Experts from Pharma/Biotech and Clinical Research Organisations (Boston, MA, United States - September 14-15, 2023)

08 May 2023
DUBLIN, May 8, 2023 /PRNewswire/ -- The "Pharmacovigilance USA Congress 2023" conference has been added to
ResearchAndMarkets.com's offering.
After witnessing outstanding success in our previous Pharmacovigilance conferences, Pharmacovigilance USA 2023 will gather the top notch Industry experts from Pharma/Biotech and Clinical Research Organisations.
Why Attend This Conference?
Listen to the top notch Pharma/Biotech Industry pioneers who will deliver the latest cutting edge information.
A fantastic opportunity to network with the top notch Pharma/Biotech Industry pioneers during the networking sessions.
Speak-out sessions and Panel discussions will provide a great opportunity to ask questions from the expert and find out feasible solutions.
Current Market Of Global Pharmacovigilance
6 Billion Pharmacovigilance Market to reach $8 Billion in 2025
1,053 Billion Global Pharmaceutical Market Value $1057 Billion
Come and Update with the expanding Global Pharmaceutical Industry and increase awareness on the significant and essential need of Global Pharmacovigilance.
Why Attend Pharmacovigilance USA
A Global Event In Pharmacovigilance
Ensuring Pharmacovigilance For Global Public Health
20+ Expert Speakers From Around The World
100's Pharma/ Biotech Professionals From Over 50 Countries
Bringing Together The Key Decision Makers Under One Roof
Over 10 Hours Of Dedicated Networking And Interactive Sessions
Who Should Attend:
Pharmacovigilance USA Congress 2023 attracts senior-level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. Delegates include VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists and professionals with intermediate to advance knowledge and experience in the following.
Pharmacovigilance Risk Management
Drug Safety Pharmacoepidemiology
Drug Research & Development Clinical Pharmacology
Clinical Safety Information And Clinical Data Management
Medical Product Safety Assessment Clinical Research & Safety
Data Analysis Information Technology
Medical Information Health Outcomes
Sales And Marketing Clinical Trials & CRO's
Contract Manufacturing
Speakers
Narayan Nair
FDA - USA
Lana Gloukhova
ATHIRA PHARMA - USA
Samirah Qureshi
ALEXION - USA
Reema Mehta
PFIZER - USA
Jenifer Kane
ENTASIS THERAPEUTICS - USA
Michael Bean
Khaudeja Bano
AMGEN - USA
Dawn Mucci
Richard Wolf
CSL Behring USA
Jaylaxmi Nalawade
Michael Von Forstner
BIOGEN - USA
Dennis L. Virgo
Dr Bert P Van Leeuwen
Alina Tudor M.D.
Dr Jackie Roberts
Edita Kaupiene, MPharm
Pharmacovigilance Project Manager
Manjit Virdee
Budhesh Dhamija
Giovanni Furlan
PFIZER
Raj Bhogal
Takeda
For more information about this conference visit https://www.researchandmarkets.com/r/nb256l
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-
Targets
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.